Editas Medicine (EDIT) Net Equity Issued and Repurchased (2015 - 2025)
Editas Medicine (EDIT) posted quarterly Net Equity Issued and Repurchased of $17.1 million for Q3 2025, up 138.7% quarter-over-quarter from $7.2 million in Q2 2025.
Editas Medicine (EDIT) Net Equity Issued and Repurchased (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported Net Equity Issued and Repurchased for 9 consecutive years, with $17.1 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $17.1 million; the TTM figure through Sep 2025 stood at $25.8 million (changed N/A YoY), while the FY2023 annual figure was $117.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased rose to $17.1 million in Q3 2025 per EDIT's latest filing, from $7.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $249.5 million in Q1 2021 and bottomed at -$11000.0 in Q2 2021.
- Historically, Net Equity Issued and Repurchased has averaged $56.0 million across 3 years, with a median of $7.2 million in 2025.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 100.88% in 2021 and fell as far as 100.01% in 2021.
- Editas Medicine's Net Equity Issued and Repurchased stood at $1000.0 in 2021, then jumped by 11709900.0% to $117.1 million in 2023, then sank by 85.36% to $17.1 million in 2025.
- Business Quant data shows EDIT's Net Equity Issued and Repurchased at $17.1 million in Q3 2025, $7.2 million in Q2 2025, and $1.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.15 Mn |
| Sep 30, 2025 | 17.15 Mn |
| Jun 30, 2025 | 7.18 Mn |
| Jun 30, 2025 | 7.18 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Jun 30, 2023 | 117.10 Mn |
| Jun 30, 2023 | 117.10 Mn |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | -11,000.00 |
| Jun 30, 2021 | -11,000.00 |
| Mar 31, 2021 | 249.47 Mn |
| Mar 31, 2021 | 249.47 Mn |
| Dec 31, 2020 | -113,000.00 |
| Dec 31, 2020 | -113,000.00 |
| Jun 30, 2020 | 203.70 Mn |
| Jun 30, 2020 | 203.70 Mn |
| Dec 31, 2019 | 75.13 Mn |
| Dec 31, 2019 | 75.13 Mn |